Noah Higgins-Dunn
FiercePharma reporter Noah Higgins-Dunn is returning to CNBC.com to cover pharmaceuticals and health.
He had joined FiercePharma earlier this year. He will start at CNBC next week.
Higgins-Dunn was a digital associate for CNBC.com covering the coronavirus. As a health and science reporter, he has covered breaking national news from the Trump administration and pharmaceutical companies racing to develop and produce COVID-19 therapeutics and vaccines.
His reporting on the opportunity gap within a mid-Missouri school district won two awards from the Missouri Press Association for best local business coverage and feature writing. He has also won a Missouri APME Award for Spot News from The Associated Press.
Higgins-Dunn graduated magna cum laude from the University of Missouri in 2019, earning a bachelor’s degree in journalism with an emphasis in business and economics reporting and a minor in business.
Reuters has named Colleen Jenkins as White House editor. She previously was a 2024 election editor and…
Ian Stevenson has been hired by E&E News to cover energy, including oil and gas and…
Bloomberg News is looking for a creative self-starter who can use data to help make…
Jim Pavia, a senior editor at CNBC, has left to become managing director of communications at…
Russell Sherman of "Press Profiles" interviewed Wall Street Journal mergers and acquisitions reporter Lauren Thomas about how she…
Rebecca Blumenstein, president of editorial at NBC News, sent out the following on Wednesday: All, I…
![](data:image/svg+xml;charset=utf-8,<svg height="300px" width="300px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="29px" width="180px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="75px" width="75px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)